Phesgo Interactions
There are 280 drugs known to interact with Phesgo (hyaluronidase/pertuzumab/trastuzumab), along with 5 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 55 are major, 143 are moderate, and 82 are minor.
- View all 280 medications that may interact with Phesgo
- View Phesgo alcohol/food interactions (2)
- View Phesgo disease interactions (5)
Most frequently checked interactions
View interaction reports for Phesgo (hyaluronidase / pertuzumab / trastuzumab) and the medicines listed below.
- anastrozole
- Andembry (garadacimab)
- atorvastatin
- biotin
- Briumvi (ublituximab)
- cephalexin
- creatine
- dexamethasone
- duloxetine
- Eliquis (apixaban)
- Enhertu (fam-trastuzumab deruxtecan)
- Entresto (sacubitril / valsartan)
- gabapentin
- Gemtesa (vibegron)
- hydroxyzine
- letrozole
- levothyroxine
- Lexapro (escitalopram)
- losartan
- magnesium glycinate
- magnesium oxide
- melatonin
- metformin
- metoclopramide
- naltrexone
- ondansetron
- Ozempic (semaglutide)
- spironolactone
- tamoxifen
- Vitamin D3 (cholecalciferol)
Phesgo alcohol/food interactions
There are 2 alcohol/food interactions with Phesgo (hyaluronidase / pertuzumab / trastuzumab).
Phesgo disease interactions
There are 5 disease interactions with Phesgo (hyaluronidase / pertuzumab / trastuzumab) which include:
More about Phesgo (hyaluronidase / pertuzumab / trastuzumab)
- Phesgo consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.